CLASS III Drug recall · Reported 24 Jul 2013 · FDA Enforcement Report

Medroxyprogesterone acetate, micronized (EP recalled by Bayer HealthCare

Bayer HealthCare Pharmaceuticals is recalling Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, distributed in California, New York. The recall was initiated on 13 Jun 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 87100040
Quantity recalled194.62 kg

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-807-2013
FDA event ID
65702
Recalling firm
Bayer HealthCare Pharmaceuticals, Morristown, NJ
Classification
Class III
Status
Terminated
Recall initiated
13 Jun 2013
FDA classified
18 Jul 2013
Reported
24 Jul 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Jun 2013Recall initiated by company
18 Jul 2013Classified by FDA+35 days
24 Jul 2013Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Where it was distributed

NY, CA

CaliforniaNew York

Questions about this recall

Why was it recalled?

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Which lots are affected?

Lot 87100040

Where was it sold?

NY, CA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bayer HealthCare Pharmaceuticals

All 30

Other Medroxyprogesterone recalls

All 24